These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3530157)

  • 21. A rabbit--in vitro system to evaluate drug action against Plasmodium falciparum.
    Mrema JE; Rieckmann KH
    Trans R Soc Trop Med Hyg; 1983; 77(1):130-5. PubMed ID: 6222522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance.
    Foote SJ; Galatis D; Cowman AF
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3014-7. PubMed ID: 2183221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro susceptibility studies of Plasmodium falciparum isolates and clones against type II antifolate drugs.
    Ang HH; Lam CK; Wah MJ
    Chemotherapy; 1996; 42(5):318-23. PubMed ID: 8874969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil.
    Fidock DA; Wellems TE
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10931-6. PubMed ID: 9380737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro selection of Plasmodium falciparum lines resistant to dihydrofolate-reductase inhibitors and cross resistance studies.
    Bhasin VK; Nair L
    Jpn J Med Sci Biol; 1996 Feb; 49(1):1-14. PubMed ID: 8799803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo susceptibility of Plasmodium falciparum isolates from Liberia to pyrimethamine, cycloguanil and chlorcycloguanil.
    Petersen E; Hogh B; Hanson AP; Bjorkman A; Flacks H
    Ann Trop Med Parasitol; 1990 Dec; 84(6):563-71. PubMed ID: 2076034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon.
    Ringwald P; Bickii J; Basco LK
    Am J Trop Med Hyg; 1996 Sep; 55(3):254-8. PubMed ID: 8842110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility studies of Plasmodium falciparum isolates and clones against cycloguanil and pyrimethamine using the modified in vitro microtechnique.
    Ang HH; Chan KL; Mak JW
    J Parasitol; 1996 Dec; 82(6):1029-31. PubMed ID: 8973418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria.
    Peterson DS; Milhous WK; Wellems TE
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3018-22. PubMed ID: 2183222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro sensitivity of Plasmodium falciparum to chlorcycloguanil in The Gambia.
    Panton LJ; Greenwood BM
    Trans R Soc Trop Med Hyg; 1985; 79(4):491-2. PubMed ID: 3909555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herbicidal properties of antimalarial drugs.
    Corral MG; Leroux J; Stubbs KA; Mylne JS
    Sci Rep; 2017 Mar; 7():45871. PubMed ID: 28361906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility studies of Malaysian Plasmodium falciparum clones to type II antifolate drugs after 3 years of continuous in vitro culture.
    Ang HH; Cheang HS; Mak JW
    Chemotherapy; 2005 Oct; 51(6):377-80. PubMed ID: 16227695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ex vivo antimalarial activity of proguanil combined with dapsone against cycloguanil-resistant Plasmodium falciparum isolates.
    Edstein MD; Yeo AE; Shanks GD; Rieckmann KH
    Acta Trop; 1997 Sep; 66(3):127-35. PubMed ID: 9210963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of artemisinin (qinghaosu) and chloroquine on drug-sensitive and drug-resistant strains of Plasmodium falciparum malaria: use of [2,8-3H]adenosine as an alternative to [G-3H]hypoxanthine in the assessment of in vitro antimalarial activity.
    Ye ZG; Van Dyke K; Wimmer M
    Exp Parasitol; 1987 Dec; 64(3):418-23. PubMed ID: 3315734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on the chemoresistance of Plasmodium falciparum in Africa: current data].
    Nguyen-Dinh P
    Ann Soc Belg Med Trop; 1985; 65 Suppl 2():105-13. PubMed ID: 3907528
    [No Abstract]   [Full Text] [Related]  

  • 36. [Mechanisms and dynamics of drug resistance in Plasmodium falciparum].
    Le Bras J
    Bull Soc Pathol Exot; 1999; 92(4):236-41. PubMed ID: 10572658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro assessment of the antimalarial activity of chloroquine and its major metabolites.
    Aderounmu AF
    Ann Trop Med Parasitol; 1984 Dec; 78(6):581-5. PubMed ID: 6398033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmodium falciparum malaria: rosettes are disrupted by quinine, artemisinin, mefloquine, primaquine, pyrimethamine, chloroquine and proguanil.
    Goldring JD; Padayachee T; Ismail I
    Mem Inst Oswaldo Cruz; 1999; 94(5):667-74. PubMed ID: 10464415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro assessment of 2-acetylpyridine thiosemicarbazones against chloroquine-resistant Plasmodium falciparum.
    Lambros C; Childs GE; Notsch JD; Scovill JP; Klayman DL; Davidson DE
    Antimicrob Agents Chemother; 1982 Dec; 22(6):981-4. PubMed ID: 6760808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of antimalarial activity of chloramphenicol against Indian Plasmodium falciparum isolates in vitro by chloroquine.
    Biswas S
    Indian J Malariol; 2002; 39(1-2):26-33. PubMed ID: 14686107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.